AVRNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Anteris Technologies Global Corp.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$6.18+0.13 (+2.15%)
Close on Oct 19, 2026
- Market cap
- $601.56M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$1.31 (+26.90%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Anteris Technologies Global Corp. saw revenue fall 9.6% to $2.24M over the twelve months to Jun 30, 2026. Free cash flow was -$88.21M.
Revenue
$2.24M
-9.6% vs. a year earlier
Operating income
-$106.23M
TTM Q2 2026
Free cash flow
-$88.21M
TTM Q2 2026
EPS, diluted
-$1.94
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $601.56M
- P/E ratio
- –
- Price to sales
- 268.32
- Price to book
- 2.39
- Dividend yield
- –
- Free cash flow yield
- -14.66%
Fundamentals
- Revenue
- $2.24M
- Net income
- -$103.56M
- EPS, diluted
- -$1.94
- Free cash flow
- -$88.21M
- Book value per share
- $2.58
- Diluted shares
- 97M
Three years at a glance
Fiscal years 2023 to 2025 and trailing twelve months, USD
Revenue
$2.24M-9.6% YoY
Gross profit
$1.68M+14.1% YoY
Operating income
-$106.23M
Net income
-$103.56M
EPS, diluted
-$1.94
Free cash flow
-$88.21M
Reported periodTrailing twelve months